Your browser doesn't support javascript.
Medical care disruptions during the first six months of the COVID-19 pandemic: the experience of older breast cancer survivors.
Dilawari, A; Rentscher, K E; Zhai, W; Zhou, X; Ahles, T A; Ahn, J; Bethea, T N; Carroll, J E; Cohen, H J; Graham, D A; Jim, H S L; McDonald, B; Nakamura, Z M; Patel, S K; Root, J C; Small, B J; Saykin, A J; Tometich, D; Van Dyk, K; Mandelblatt, J S.
  • Dilawari A; Medstar Washington Hospital Center, Washington, DC, 20007, USA.
  • Rentscher KE; Georgetown-Lombardi Comprehensive Cancer Center, Georgetown University, 3300 Whitehaven Blvd, Suite 4100, Washington, DC, USA.
  • Zhai W; Cousins Center for Psychoneuroimmunology, University of California, Los Angeles, CA, USA.
  • Zhou X; Department of Psychiatry & Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, CA, USA.
  • Ahles TA; Georgetown-Lombardi Comprehensive Cancer Center, Georgetown University, 3300 Whitehaven Blvd, Suite 4100, Washington, DC, USA.
  • Ahn J; Department of Biostatistics, Bioinformatics, and Biomathematics, Georgetown University, Washington, DC, USA.
  • Bethea TN; Georgetown-Lombardi Comprehensive Cancer Center, Georgetown University, 3300 Whitehaven Blvd, Suite 4100, Washington, DC, USA.
  • Carroll JE; Department of Biostatistics, Bioinformatics, and Biomathematics, Georgetown University, Washington, DC, USA.
  • Cohen HJ; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Graham DA; Cousins Center for Psychoneuroimmunology, University of California, Los Angeles, CA, USA.
  • Jim HSL; Georgetown-Lombardi Comprehensive Cancer Center, Georgetown University, 3300 Whitehaven Blvd, Suite 4100, Washington, DC, USA.
  • McDonald B; Department of Psychiatry & Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, CA, USA.
  • Nakamura ZM; Department of Biostatistics, Bioinformatics, and Biomathematics, Georgetown University, Washington, DC, USA.
  • Patel SK; Center for the Study of Aging and Human Development, Duke University Medical Center, Durham, NC, USA.
  • Root JC; John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ, USA.
  • Small BJ; Moffitt Cancer Center, Tampa, FL, USA.
  • Saykin AJ; Department of Radiology and Imaging Sciences, Indiana University School of Medicine and Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN, USA.
  • Tometich D; Department of Psychiatry, University of North Carolina-Chapel Hill, Chapel Hill, NC, USA.
  • Van Dyk K; City of Hope National Medical Center, Los Angeles, CA, USA.
  • Mandelblatt JS; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Breast Cancer Res Treat ; 190(2): 287-293, 2021 Nov.
Article in English | MEDLINE | ID: covidwho-1404658
Preprint
This scientific journal article is probably based on a previously available preprint. It has been identified through a machine matching algorithm, human confirmation is still pending.
See preprint
ABSTRACT

PURPOSE:

Older cancer survivors required medical care during the COVID-19 pandemic, but there are limited data on medical care in this age group.

METHODS:

We evaluated care disruptions in a longitudinal cohort of non-metastatic breast cancer survivors aged 60-98 from five US regions (n = 321). Survivors completed a web-based or telephone survey from May 27, 2020 to September 11, 2020. Care disruptions included interruptions in seeing or speaking to doctors, receiving medical treatment or supportive therapies, or filling prescriptions since the pandemic began. Logistic regression models evaluated associations between care disruptions and education, medical, psychosocial, and COVID-19-related factors. Multivariate models included age, county COVID-19 death rates, comorbidity, and post-diagnosis time.

RESULTS:

There was a high response rate (n = 262, 81.6%). Survivors were 32.2 months post-diagnosis (SD 17.5, range 4-73). Nearly half (48%) reported a medical disruption. The unadjusted odds of care disruptions were higher with each year of education (OR 1.22, 95% CI 1.08-1.37, p = < 0.001) and increased depression by CES-D score (OR 1.04, CI 1.003-1.08, p = 0.033) while increased tangible support decreased the odds of disruptions (OR 0.99, 95% CI 0.97-0.99, p = 0.012). There was a trend between disruptions and comorbidities (unadjusted OR 1.13 per comorbidity, 95% CI 0.99-1.29, p = 0.07). Adjusting for covariates, higher education years (OR1.23, 95% CI 1.09-1.39, p = 0.001) and tangible social support (OR 0.98 95% CI 0.97-1.00, p = 0.006) remained significantly associated with having care disruptions.

CONCLUSION:

Older breast cancer survivors reported high rates of medical care disruptions during the COVID-19 pandemic and psychosocial factors were associated with care disruptions. CLINICALTRIALS. GOV IDENTIFIER NCT03451383.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Breast Neoplasms / Cancer Survivors / COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study Limits: Aged / Female / Humans / Middle aged Language: English Journal: Breast Cancer Res Treat Year: 2021 Document Type: Article Affiliation country: S10549-021-06362-w

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Breast Neoplasms / Cancer Survivors / COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study Limits: Aged / Female / Humans / Middle aged Language: English Journal: Breast Cancer Res Treat Year: 2021 Document Type: Article Affiliation country: S10549-021-06362-w